combination therapy

Jajoo A, Margolin K, Limketkai BN, Parian A. Evolution of Advanced Combination Treatment in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2025 Dec;21(12):745-756. PMID: 41647471;[...]

O'Reilly EM, Cabanski CR, Lyman JP, Wainberg ZA, Fisher GA, Wolff RA, Ko AH, O'Hara MH, Spencer CN, Yu JX, Da Silva DM, Padrón LJ,[...]

Bleick CR, Van Helden SR, Berti AD, Richa R, Lehman SM, Bayer AS, Rybak MJ. Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible[...]

Rose WE, Ersoy SC, Abdelhady W, Dominguez AR, Muyah Manna JN, Artaza JN, Mishra R, Elsayed AM, Proctor RA, Baines SL, Howden BP, Mishra NN.[...]

Kim NH, Chin KM, McLaughlin VV, Ong R, MacDonald G, Martin N, Senatore A, Channick R. Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary[...]

Vale C, Lourenço IM, Jordan G, Golovaty I, Torres H, Moin T, Buysschaert M, Neves JS, Bergman M. Early combination therapy with SGLT2i and GLP-1[...]

Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.

Chin KM, Channick R, Kim NH, MacDonald G, Ong R, Martin N, Senatore A, McLaughlin VV. Macitentan and Tadalafil Combination Therapy in Incident and Prevalent[...]

Gebremariam T, Alkhazraji S, Gu Y, Najvar LK, Borroto-Esoda K, Patterson TF, Filler SG, Wiederhold NP, Ibrahim AS. Ibrexafungerp is efficacious in a neutropenic murine[...]

Rotstein C, Lynch JP 3rd, Zhanel GG. Hospital-acquired bacterial pneumonia (HABP) and ventilator- associated bacterial pneumonia (VABP) in Canada:treatment update and the role of new[...]